Craig Clark is a seasoned professional with twenty years of experience in the highly regulated pharmaceutical industry. They have cultivated a broad background in pharmaceutical validation, process engineering, and project management, contributing significantly to areas such as parenteral bulk manufacturing and regulatory affairs. Craig currently serves as the Sr. Director of CT Parenteral Manufacturing Operations at Eli Lilly and Company, a role they have held since 2024, after previously working in various capacities at organizations like Elan Pharmaceuticals and Sigma-Tau Pharmasource. Additionally, Craig is pursuing a Bachelor of Science in Chemical Engineering at the Rose-Hulman Institute of Technology.
This person is not in any teams
This person is not in any offices